FATE

FATE THERAPEUTICS INC

Healthcare | Micro Cap

-$0.25

EPS Forecast

$1.57

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

-$0.25

Revenue Forecast:

$1.57

EPS Surprise Forecast:

$0.018

Revenue Surprise Forecast:

$0

Post-release price volatility - High

Post-release Overnight Move:

±8.2%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

65%

Probability of beating revenue consensus:

53%

Probability of beating both EPS & revs consensus:

40%

Probability of missing both EPS & revs consensus:

22%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

0

Beta (β)

Forward Looking Beta (β):

1.34

Earnings volatility

EPS standard deviation:

$0.08

Revenue standard deviation:

$5

As % of share price:

3.72% EXTREME UNCERTAINTY

As % of market cap:

1.79% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

-$0.16

Revenue 95th %ile:

$7

EPS 75th %ile:

-$0.23

Revenue 75th %ile:

$3

EPS 25th %ile:

-$0.28

Revenue 25th %ile:

$0

EPS 5th %ile:

-$0.35

Revenue 5th %ile:

-$3

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

38% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

79% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$45

Bid-ask per Share:

$0.01